Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Bullboard Posts
Comment by amendison Aug 20, 2014 1:46pm
206 Views
Post# 22861097

RE:RE:RE:Report out today Thomson Reuters stock report+ Rating 7

RE:RE:RE:Report out today Thomson Reuters stock report+ Rating 7unknown991 Can you find a bio Tech or any company trading .50cts Has 5 Quarts profit and this year end profit near million or above million. 3 golden eggs going to give birth. SST two to three month away from field trials. Management and plus this board plus institutional investors , you can call as serial investors below 20%, that means 56 million are in not serious hands. They can put in to the market few cents or few dollars. How good the news this short sellers buy back with out any problem. Management hold 50 or more percentage. less public float. short sellers are fear to borrow and sell to the market. MBX cannot be 0.50 cent. now this should be above 1.40 range. We need Intuitional or management to buy and keep longer term.
Bullboard Posts